Bio Pharma Dive

NOVEMBER 9, 2021

rights to rimegepant — a sizable licensing deal, though not the buyout that some of the biotech's investors appeared to be hoping for. The pharmaceutical giant will pay Biohaven $500 million for ex-U.S.

Medicine 265

Medicine Licensing Licensing 265

Pharmaceutical Technology

OCTOBER 4, 2022

Shionogi & Co and the United Nations (UN)-backed public health organisation Medicines Patent Pool (MPP) have entered a voluntary licence agreement for the former’s oral Covid-19 antiviral candidate ensitrelvir fumaric acid (S-217622).

Licensing 147

Licensing Licensing Manufacturing Medicine 147

Pharmaceutical Technology

AUGUST 11, 2022

Gemini Therapeutics has signed a definitive agreement to merge with Disc Medicine in an all-stock deal to create a clinical-stage biopharmaceutical company. The merged company is expected to be named Disc Medicine, which will have corporate headquarters in Watertown, Massachusetts, US. Last year, Disc in-licensed bitopertin from Roche.

Medicine 147

Medicine Clinical Trials Clinical Trials Licensing 147

Bio Pharma Dive

APRIL 23, 2024

Shares of the biotech rose about 5% after a medicine licensed from Takeda hit the main and key secondary goals of a mid-stage study focused on major depressive disorder.

Licensing 156

Licensing Licensing Drugs Medicine 156

Pharmaceutical Technology

JANUARY 23, 2023

“We look forward to utilising our development and commercial capabilities to expand the potential of this innovative medicine to patients beyond China. “We We have a strong track record of working with companies that share our focus on bringing transformative medicines to patients around the globe who need them.”

Licensing 130

Licensing Licensing Sales Branding 130

Pharmaceutical Technology

JUNE 19, 2023

Bio-Thera Solutions and Biomm have entered a licensing and supply agreement for Bio-Thera’s BAT2206, a ustekinumab biosimilar. It plans to seek regulatory approval from the European Medicines Agency, the China National Medical Products Administration and the US Food and Drug Administration.

Licensing 130

Licensing Licensing Clinical Trials Clinical Trials 130

Pharmaceutical Technology

APRIL 25, 2023

German biotechnology firm 3B Pharmaceuticals (3BP) has entered into a licensing agreement with Novartis Innovative Therapies for its fibroblast activation protein (FAP)-targeting peptide technology. 3BP receives an initial payment of $40m, and $425m as development, regulatory and commercial milestone payments.

Licensing 130

Licensing Licensing Clinical Development Clinical Trials 130

Pharmaceutical Technology

JULY 28, 2022

“By leveraging our expansive commercial infrastructure, we will provide the resources needed to optimise the commercialisation of rezafungin and ensure patient access to this life-saving medicine in the US. “We The post Melinta and Cidara sign licensing deal for rezafungin appeared first on Pharmaceutical Technology.

Licensing 147

Licensing Licensing Clinical Trials Clinical Trials 147

Bio Pharma Dive

OCTOBER 27, 2021

The deal with the Medicines Patent Pool is meant to increase access in lower-income countries to molnupiravir, an experimental drug that could become the first oral treatment for COVID-19.

Licensing 315

Licensing Licensing Medicine Drugs 315

Pharmaceutical Technology

MARCH 17, 2023

Pharmanovia and Aeterna Zentaris have entered an exclusive licensing agreement for the latter’s medicine Ghryvelin (macimorelin). Under the deal, Pharmanovia will acquire the exclusive rights and license to commercialise Ghryvelin in the EEA and the UK from Consilient Health.

Hormones 263

Hormones Licensing Licensing Medicine 263

Bio Pharma Dive

AUGUST 2, 2022

Founded by serial entrepreneur Alexis Borisy, the company comes equipped with two experimental medicines it licensed from Merck KGaA and Blueprint Medicines.

Licensing 300

Licensing Licensing Development Medicine 300

Bio Pharma Dive

APRIL 3, 2023

The biotech is expanding its cancer medicine pipeline by licensing two experimental antibody drug conjugates from Shanghai-based Duality.

Licensing 287

Licensing Licensing Antibody Medicine 287

Bio Pharma Dive

MAY 31, 2023

The medicine, licensed from biotech ImmuNext in 2017, is one of two later-stage MS drug prospects in the French drugmaker’s portfolio.

Licensing 265

Licensing Licensing Drugs Medicine 265

STAT News

OCTOBER 20, 2022

Amid a push to widen access to medicines to poor countries, Novartis has reached an agreement to license one of its best-selling cancer treatments so that generic manufacturers can produce copies for distribution to 44 low- and middle-income nations. Continue to STAT+ to read the full story…

Licensing 98

Licensing Licensing Medicine Manufacturing 98

STAT News

JULY 28, 2022

In a much ballyhooed move, ViiV Healthcare finalized a deal to license its long-acting injectable HIV prevention shot to the Medicines Patent Pool so that generic companies can make and distribute lower-cost versions to low- and middle-income countries.

Licensing 98

Licensing Licensing Medicine Manufacturing 98

BioSpace

DECEMBER 11, 2023

Backed by ARCH Venture Partners and Fujifilm, as well as technology licensed from MIT, Tome is looking to create curative cell and integrative gene therapies.

Gene Therapy 118

Gene Therapy Genome Genomics Medicine 118

BioTech 365

NOVEMBER 18, 2020

Foundation Medicine Enters into Patent Licensing and Technology Agreement with TwinStrand Biosciences Foundation Medicine Enters into Patent Licensing and Technology Agreement with TwinStrand Biosciences CAMBRIDGE, Mass.–(BUSINESS

Licensing 52

Licensing Licensing Medicine 52

Bio Pharma Dive

DECEMBER 14, 2021

Fitusiran, which Sanofi licensed from Alnylam, could finally get to market after trial delays and safety concerns slowed its progress. But gene therapies and other new medicines might provide competition.

Gene Therapy 317

Gene Therapy Licensing Licensing Gene 317

BioPharma Reporter

DECEMBER 7, 2023

Symbiosis Pharmaceutical Services can now test small molecule, biological and advanced therapeutical medicinal products (ATMP) following a Â1 million investment.

Licensing 98

Licensing Licensing Medicine Production 98

Fossil Remedies

OCTOBER 16, 2022

To launch the best PCD pharma franchise company, you will have to acquire the necessary licenses from authorities. The next important thing is the license. Every pharma company needs a drug license number to begin distribution, marketing, and manufacturing activities. License required to start a Pharmaceutical Business in India.

Licensing 52

Licensing Licensing Pharma Companies Cosmetics 52

BioTech 365

AUGUST 17, 2021

Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer Novel discovery and research originated from Universidad Central del Caribe … Continue reading → (..)

Licensing 40

Licensing Licensing Medicine Research 40

Bio Pharma Dive

JANUARY 31, 2023

For $10 million up front, UniQure has licensed rights to its second experimental treatment for the condition, a medicine from startup Apic Bio that should enter human testing later this year.

Gene Therapy 210

Gene Therapy Gene Licensing Licensing 210

STAT News

DECEMBER 21, 2022

California authorities are seeking to revoke a license held by a CVS Health mail-order pharmacy unit for violating several state laws that govern shipments of various controlled substances — including prescription painkillers and ADHD medicines — directly to patients.

Licensing 105

Licensing Licensing Pharmacy Medicine 105

Scienmag

JANUARY 12, 2022

Nicholas Hopkinson at Imperial College London welcomes the move, saying this will give doctors another means to help smokers quit. E-cigarettes are currently regulated as consumer products so cannot be promoted as smoking cessation aids, he explains.

Licensing 59

Licensing Licensing Medicine Doctors 59

Medical Xpress

MARCH 30, 2023

In a recent interview posted on JMIR TV, JMIR Publications' CEO Dr. Gunther Eysenbach speaks with Dr. Andrew Taylor from Yale University School of Medicine about their paper titled "How Does ChatGPT Perform on the United States Medical Licensing Examination?

Licensing 61

Licensing Licensing Medicine 61

BioTech 365

OCTOBER 27, 2021

The Medicines Patent Pool (MPP) and Merck Enter Into License Agreement for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, to Increase Broad Access in Low- and Middle-Income Countries The Medicines Patent Pool (MPP) and Merck Enter Into License Agreement for … Continue reading →

Licensing 52

Licensing Licensing Medicine 52

pharmaphorum

OCTOBER 21, 2022

The Medicines Patent Pool (MPP) and Novartis have unveiled a new voluntary licensing agreement to allow generic drugmakers in seven middle income nations to develop, manufacture, and supply generic versions of the leukaemia treatment nilotinib. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia (CML).

Medicine 57

Medicine Licensing Licensing Drugs 57

BioTech 365

JUNE 25, 2021

Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA) Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA) VICTORIA, British … Continue reading (..)

Licensing 52

Licensing Licensing Medicine Marketing 52

STAT News

OCTOBER 20, 2022

Three dozen institutional investors are urging the boards at several of the world’s largest pharmaceutical companies to establish concrete metrics for linking executive compensation with policies that widen access to medicines to low- and middle-income countries.

Medicine 98

Medicine Licensing Licensing Production 98

Bio Pharma Dive

MAY 30, 2023

The biotech, which went public in 2021 to develop a cancer drug licensed from Daiichi Sankyo, may try to acquire a different tumor-targeting medicine to grow its pipeline.

Licensing 139

Licensing Licensing Medicine Development 139

Scienmag

MARCH 7, 2022

announced that the Institute’s electrochemical eRapid technology has been licensed to Antisoma Therapeutics Pty. The licensing agreement was coordinated by Harvard University’s Office of Technology Development and grants the company exclusive, worldwide access to the Wyss Institute’s […]. a subsidiary of The iQ Group Global.

Licensing 91

Licensing Licensing Engineer Development 91

pharmaphorum

NOVEMBER 16, 2022

The 2022 edition of the Access to Medicine Index (ATMI) – which places the top 20 pharma companies for their efforts to improve delivery of medicines to lower income countries – sees GSK retain the number one position, newly joined by Johnson & Johnson in second and AstraZeneca in third. Jayasree Iyer.

Medicine 103

Medicine Production Pharma Companies Licensing 103

Bio Pharma Dive

MARCH 30, 2023

The licensing deal for the FDA-approved medicine, Brexafemme, includes milestone payments that could add up to $503 million.

FDA Approval 148

FDA Approval Licensing Licensing Medicine 148

Drug Discovery World

FEBRUARY 16, 2023

Challenges remain with current delivery approaches, and genetic medicines applications have been generally restricted to the liver and ex vivo settings. Aera’s technology also includes a licensed therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene editing enzymes.

Genetics 52

Genetics Medicine Gene Editing In-Vivo 52

Bio Pharma Dive

OCTOBER 27, 2020

The startup, which aims to develop lower-cost alternatives to branded medicines, has licensed two drugs from CStone Pharmaceuticals in a deal that could signal a coming price war in cancer immunotherapy.

Licensing 265

Licensing Licensing Branding Drugs 265

Bio Pharma Dive

FEBRUARY 24, 2023

The pharma is handing back rights to an experimental medicine for the liver disease that had been licensed from biotech Pliant Therapeutics.

Licensing 139

Licensing Licensing Research Medicine 139

Outsourcing Pharma

JANUARY 29, 2024

The Pistoia Alliance has published its Identification of Medicinal Products (IDMP) Ontology 1.0 under an open-source license.

Life Science 105

Life Science Licensing Licensing Medicine 105